Latest financial market updates and expert analysis
Analysis Facing a pivotal moment after a significant clinical disappointment, biopharmaceutical firm Adlai Nortye has undertaken a comprehensive strategic realignment. The company is now channeling its resources and investor attention toward...
The B Riley Principal 250 Merger special purpose acquisition company (SPAC) has been formally liquidated, concluding its corporate existence. This...
The latest quarterly report from UL Solutions Inc. Class A shares presented a strong set of results that surpassed market...
Virgin Galactic is accelerating its strategic pivot, shifting focus to the next generation of its spacecraft fleet. The cornerstone of...
Investor focus is intensifying on Artiva Biotherapeutics as the company approaches several significant near-term catalysts from its clinical development pipeline....
The shares of Femasys concluded the prior trading week with little fanfare, as the company’s market valuation held near $32...
The SGS Group is undertaking a significant reassessment of its long-term strategic goals. With recent financial maneuvers and portfolio shifts...
Former shareholders of Endeavor Group Holdings face a critical deadline. Multiple law firms are urging investors to step forward as...
In the absence of company-specific news, the trajectory of Sequans Communications’ shares is being shaped by broader industry currents. With...
Kyndryl Holdings Incorporation finds itself navigating a perfect storm of analyst pessimism, disappointing financial results, and internal control failures. The...
As Innovative Industrial Properties (IIPR) prepares to release its quarterly figures on Monday, a palpable sense of apprehension has taken...
